Department of Neurosurgery, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Department of Neuroradiology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Acta Neurochir (Wien). 2022 Nov;164(11):2917-2926. doi: 10.1007/s00701-022-05347-y. Epub 2022 Aug 25.
The appropriate management of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH) remains uncertain. We aimed to evaluate the effect of implementing a standardized protocol for detection and management of DCI after aSAH on cerebral infarction and functional outcome.
We studied two cohorts of aSAH patients, one before (pre-implementation cohort: January 2012 to August 2014) and one after (post-implementation cohort: January 2016 to July 2018) implementation of a multidisciplinary approach, with standardized neurological and radiological assessment and risk-based medical treatment of DCI. We assessed the presence of new hypodensities on CT within 6 weeks after aSAH and categorized cerebral infarction into overall and DCI-related infarctions (hypodensities not within 48 h after IA repair and not attributable to aneurysm occlusion or intraparenchymal hematoma). Functional outcome was assessed at 3 months using the extended Glasgow outcome scale (eGOS), dichotomized into unfavorable (eGOS: 1-5) and favorable (eGOS: 6-8). We calculated odds ratios (OR) with corresponding 95% confidence intervals (CI's), and adjusted for age, WFNS grade, Fisher score, and treatment modality (aOR).
In the post-implementation (n = 158) versus the pre-implementation (n = 143) cohort the rates for overall cerebral infarction were 29.1% vs 46.9% (aOR: 0.41 [0.24-0.69]), for DCI-related cerebral infarction 17.7% vs. 31.5% (aOR: 0.41 [0.23-0.76]), and for unfavorable functional outcome at 3 months 37.3% vs. 53.8% (aOR: 0.30 [0.17-0.54]). For patients with DCI, the rates for unfavorable functional outcomes at 3 months in the post-implementation versus the pre-implementation cohort were 42.3% vs. 77.8% (aOR: 0.1 [0.03-0.27]).
A multidisciplinary approach with more frequent and standardized neurological assessment, standardized CT and CT perfusion monitoring, as well as tailored application of induced hypertension and invasive rescue therapy strategies, is associated with a significant reduction of cerebral infarction and unfavorable functional outcome after aneurysmal aSAH.
对动脉瘤性蛛网膜下腔出血(aSAH)后迟发性脑缺血(DCI)的适当处理仍存在不确定性。我们旨在评估在 aSAH 后实施检测和处理 DCI 的标准化方案对脑梗死和功能结果的影响。
我们研究了两组 aSAH 患者,一组在(实施前队列:2012 年 1 月至 2014 年 8 月)之前,另一组在(实施后队列:2016 年 1 月至 2018 年 7 月)之后,采用多学科方法,对 DCI 进行标准化的神经学和放射学评估,并根据风险进行医学治疗。我们评估了 aSAH 后 6 周内 CT 上的新低密度区,并将脑梗死分为总梗死和 DCI 相关梗死(低密度区不在 IA 修复后 48 小时内,并且与动脉瘤闭塞或脑实质血肿无关)。在 3 个月时使用扩展格拉斯哥结局量表(eGOS)评估功能结局,分为不良结局(eGOS:1-5)和良好结局(eGOS:6-8)。我们计算了比值比(OR)及其相应的 95%置信区间(CI),并根据年龄、WFNS 分级、Fisher 评分和治疗方式(调整后的 OR,aOR)进行了调整。
在实施后(n=158)与实施前(n=143)队列中,总脑梗死发生率分别为 29.1%和 46.9%(aOR:0.41 [0.24-0.69]),DCI 相关脑梗死发生率分别为 17.7%和 31.5%(aOR:0.41 [0.23-0.76]),3 个月时不良功能结局发生率分别为 37.3%和 53.8%(aOR:0.30 [0.17-0.54])。对于 DCI 患者,在实施后与实施前队列中,3 个月时不良功能结局的发生率分别为 42.3%和 77.8%(aOR:0.1 [0.03-0.27])。
多学科方法,包括更频繁和标准化的神经学评估、标准化 CT 和 CT 灌注监测,以及量身定制的诱导高血压和侵入性抢救治疗策略的应用,与动脉瘤性蛛网膜下腔出血后脑梗死和不良功能结局的发生率显著降低相关。